Navigation Links
Research network at St. Michael's gets $4.7 million to study classes of drugs
Date:7/5/2013

TORONTO, July 5, 2013An Ontario-wide research network based at St. Michael's Hospital has received a three-year, $4.7 million grant from the province of Ontario to conduct policy-driven prescription drug research.

The grant from the Health Services Research Fund was awarded to the Ontario Drug Policy Research Network to bridge drug policy and research. The co-principal investigators of the network are Tara Gomes and Dr. Muhammad Mamdani, both scientists at the hospital's Li Ka Shing Knowledge Institute, as well as Dr. David Juurlink of Sunnybrook Health Sciences Centre.

Since being established in 2008, the network has worked directly with health policy-makers in Ontario to generate rigorous evidence related to drug safety, effectiveness and costs to inform drug policy. This new grant will allow the network to conduct comprehensive reviews of entire classes of drugs, rather than individual drugs, and will nearly double its full-time and part-time staff to approximately 15 people, Gomes said.

Gomes said their work will include systematic reviews of literature, economic analyses, pharmacoepidemiologic evaluations, and qualitative studies of the perceptions and values of patients, prescribers and pharmacists. This work will consider a broad range of areas, including the effectiveness of the drugs, potential side effects, how they are being prescribed in Ontario and the cost implications of any changes to their coverage on the public drug plan. Ontario spends nearly $5 billion annually on core drug programs, making it one of the world's largest public payers for drugs. Work by the Ontario Drug Policy Research Network so far has the potential to save the Ontario health care system at least $26 million in spending over the next five years, while at the same time improving the quality of care and health outcomes.

"Our network provides Ontario decision-makers with evidence to inform drug policy decisions and to ensure that drugs are provided in a way that is safe, cost-effective, and that aligns with patient and provider values," Gomes said.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert

Related medicine news :

1. New research could pave the way to safer treatments for arthritis
2. IRCM scientists find a novel research model for the study of auto-immune diseases
3. Researcher warns banned fountain of youth drug may be making a comeback
4. IOF 4th Asia-Pacific Osteoporosis Meeting is influential forum for regional bone research
5. Researchers pinpoint sources of fibrosis-promoting cells that ravage organs
6. Researchers use immunocytochemistry to determine ALK status
7. Researchers find 2 new methods to determine ALK status
8. CWRU researchers trace inner-city womens health issues to childhood traumas
9. Penn Medicine researchers discover link between fear and sound perception
10. Grant to further childhood sarcoma therapeutic research
11. UCI researchers awarded $2.27 million to create novel diabetes treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... ... July 25, 2017 , ... ... it will be exhibiting and providing demos of its smart journaling platform at ... Convention Center in Washington D.C. from August 3-6, 2017. , The APA Annual ...
(Date:7/25/2017)... ... July 25, 2017 , ... Nautilus ... United States, today announced its partnership with financial technology company, Automated Transaction Delivery ... of the solution lies within Hyosung’s superior ATMs, assisted self-service devices and associated ...
(Date:7/25/2017)... ... July 25, 2017 , ... Facing medical needs with a newborn boy this ... of a new benefit for employees that is uncommon in American business: 12 weeks ... supports me and other employees as new parents. It keeps our family life more ...
(Date:7/25/2017)... TX (PRWEB) , ... July 25, 2017 , ... SignatureCare ... emergencies in the Austin, TX area 24 Hours a day. , The ... Austin, TX. , “We’ve been open four months now and things are running ...
(Date:7/24/2017)... JACKSONVILLE, Florida (PRWEB) , ... ... ... Klaproth, Division Marketing Director,      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins ... guests joined together to celebrate the structural topping out of the new ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences Inc. ... to support the development of CRISPR-Cas3 antimicrobial therapeutics. Financing ... a leading Chinese Internet services provider, and joined by ... multiple infectious disease product programs targeting antibiotic resistant infections ... Founded by Dr. Rodolphe Barrangou and ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), today announced that it has reached ... holder and largest shareholder, to modify its existing credit ... to the modification, WAVI agreed to exchange its existing ...
Breaking Medicine Technology: